SAB Biotherapeutics reports Q1 2026 results, enrollment progress

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. CRWV
10. NOW

Go back to SAB Biotherapeutics reports Q1 2026 results, enrollment progress
(NASDAQ: SABS) Delayed: 3.41 +0.03 (0.89%)
Previous Close $3.38    52 Week High $ 
Open $3.40    52 Week Low $ 
Day High $3.55    P/E N/A 
Day Low $3.33    EPS $ 
Volume 239,047       

(NASDAQ: SABSW) Delayed: 0.01 --0 (-0%)
Previous Close $0.01    52 Week High $ 
Open $0.01    52 Week Low $ 
Day High $0.01    P/E N/A 
Day Low $0.01    EPS $ 
Volume 9,301